Literature DB >> 22269944

Visual pathway axonal loss in benign multiple sclerosis: a longitudinal study.

Kristin M Galetta1, Jennifer Graves, Lauren S Talman, Deacon J Lile, Elliot M Frohman, Peter A Calabresi, Steven L Galetta, Laura J Balcer.   

Abstract

BACKGROUND: Benign multiple sclerosis (MS), traditionally defined as Expanded Disability Status Scale (EDSS) score ≤3 and ≥15-year disease duration, is thought to follow a milder clinical course. We determined the extent of visual pathway axonal loss by optical coherence tomography (OCT) retinal nerve fiber layer (RNFL) thickness in a benign MS cohort and examined the relation to vision and quality of life (QOL).
METHODS: In this longitudinal study of vision in MS at 3 academic centers, a subset of patients with EDSS, visual function, OCT, and QOL assessments was analyzed. Low- and high-contrast letter acuity was performed to assess visual function. RNFL thickness was determined using time-domain OCT. QOL scales included the 25-Item National Eye Institute Visual Functioning Questionnaire (NEI-VFQ-25) and Short Form-36 Health Survey.
RESULTS: Among 68 patients (135 eyes) studied longitudinally, 13 (26 eyes) had benign MS using criteria of EDSS score ≤3 and ≥15-year disease duration. Benign MS eyes had as much RNFL thinning (-3.6 μm, P = 0.0008 vs baseline, paired t test) as typical MS eyes (-3.3 μm, P < 0.0001). Both groups had significant low-contrast acuity loss. History of optic neuritis (ON) was more frequent in benign MS (69% vs 33% of eyes). History of ON distinguished benign vs typical MS (P = 0.002) and correlated with RNFL thickness at baseline (P = 0.002) and disease duration (P = 0.03) but not EDSS (P = 0.32, logistic regression). NEI-VFQ-25 scores were also worse for benign MS, accounting for age (75 ± 21 vs 88 ± 11, P = 0.005).
CONCLUSION: Patients with benign MS have RNFL axonal loss that is as marked as that of typical MS and have reduced vision and QOL. While overall neurologic impairment is mild, visual dysfunction, not well captured by the EDSS, accounts for a substantial degree of disability in benign MS.

Entities:  

Mesh:

Year:  2012        PMID: 22269944      PMCID: PMC3427935          DOI: 10.1097/WNO.0b013e318240204d

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  45 in total

1.  Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study.

Authors:  E Portaccio; V Zipoli; B Goretti; N De Stefano; M P Amato
Journal:  Mult Scler       Date:  2009-03       Impact factor: 6.312

2.  "Benign" and "normal appearing": it's in the eye of the beholder.

Authors:  Frederik Barkhof
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-01       Impact factor: 10.154

3.  A diffusion tensor MRI study of cervical cord damage in benign and secondary progressive multiple sclerosis patients.

Authors:  B Benedetti; M A Rocca; M Rovaris; D Caputo; M Zaffaroni; R Capra; A Bertolotto; V Martinelli; G Comi; M Filippi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-06-21       Impact factor: 10.154

4.  Benign or not benign MS: a role for routine neuropsychological assessment?

Authors:  Ralph H B Benedict; Franz Fazekas
Journal:  Neurology       Date:  2009-07-29       Impact factor: 9.910

5.  Cortical functional reorganization and its relationship with brain structural damage in patients with benign multiple sclerosis.

Authors:  Antonio Giorgio; Emilio Portaccio; Maria Laura Stromillo; Silvia Marino; Valentina Zipoli; Marco Battaglini; Anita Blandino; Maria Letizia Bartolozzi; Gianfranco Siracusa; Maria Pia Amato; Nicola De Stefano
Journal:  Mult Scler       Date:  2010-07-29       Impact factor: 6.312

6.  How long can you keep working with benign multiple sclerosis?

Authors:  Solveig B Glad; Harald Nyland; Jan Harald Aarseth; Trond Riise; Kjell-Morten Myhr
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-08-27       Impact factor: 10.154

7.  Long-term follow-up of benign multiple sclerosis in Hordaland County, Western Norway.

Authors:  S B Glad; H I Nyland; J H Aarseth; T Riise; K M Myhr
Journal:  Mult Scler       Date:  2009-07-01       Impact factor: 6.312

8.  Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.

Authors:  E Portaccio; M L Stromillo; B Goretti; V Zipoli; G Siracusa; M Battaglini; A Giorgio; M L Bartolozzi; L Guidi; S Sorbi; A Federico; M P Amato; N De Stefano
Journal:  Neurology       Date:  2009-07-29       Impact factor: 9.910

Review 9.  MRI features of benign multiple sclerosis: toward a new definition of this disease phenotype.

Authors:  M Rovaris; F Barkhof; M Calabrese; N De Stefano; F Fazekas; D H Miller; X Montalban; C Polman; M A Rocca; A J Thompson; T A Yousry; M Filippi
Journal:  Neurology       Date:  2009-05-12       Impact factor: 9.910

10.  In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis.

Authors:  B Benedetti; M Rovaris; M A Rocca; D Caputo; M Zaffaroni; R Capra; A Bertolotto; V Martinelli; G Comi; M Filippi
Journal:  Mult Scler       Date:  2009-05-22       Impact factor: 6.312

View more
  12 in total

1.  Ophthalmic Manifestations of Amyotrophic Lateral Sclerosis (An American Ophthalmological Society Thesis).

Authors:  Nicholas J Volpe; Joseph Simonett; Amani A Fawzi; Teepu Siddique
Journal:  Trans Am Ophthalmol Soc       Date:  2015

Review 2.  Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection.

Authors:  Reiko E Sakai; Daniel J Feller; Kristin M Galetta; Steven L Galetta; Laura J Balcer
Journal:  J Neuroophthalmol       Date:  2011-12       Impact factor: 3.042

Review 3.  Can Optical Coherence Tomography Be Used to Guide Treatment Decisions in Adult or Pediatric Multiple Sclerosis?

Authors:  Jeffrey Lambe; Olwen C Murphy; Shiv Saidha
Journal:  Curr Treat Options Neurol       Date:  2018-03-21       Impact factor: 3.598

4.  Evaluation of changes in retinal nerve fiber layer thickness and visual functions in cases of optic neuritis and multiple sclerosis.

Authors:  Rohit Saxena; Gopal Bandyopadhyay; Digvijay Singh; Sumit Singh; Pradeep Sharma; Vimla Menon
Journal:  Indian J Ophthalmol       Date:  2013-10       Impact factor: 1.848

Review 5.  [Optical coherence tomography in neuromyelitis optica spectrum disorders].

Authors:  F C Oertel; H Zimmermann; A U Brandt; F Paul
Journal:  Nervenarzt       Date:  2017-12       Impact factor: 1.214

6.  Benign Multiple Sclerosis is Associated with Reduced Thinning of the Retinal Nerve Fiber and Ganglion Cell Layers in Non-Optic-Neuritis Eyes.

Authors:  Yu Min Huang-Link; Mats Fredrikson; Hans Link
Journal:  J Clin Neurol       Date:  2015-05-28       Impact factor: 3.077

7.  Infectious and noninfectious granulomatosis in patient with multiple sclerosis: diagnostic dilemmas and followup.

Authors:  Jelena Paovic; Predrag Paovic; Vojislav Sredovic
Journal:  Case Reports Immunol       Date:  2014-02-17

Review 8.  Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis.

Authors:  Laura J Balcer; Jenelle Raynowska; Rachel Nolan; Steven L Galetta; Raju Kapoor; Ralph Benedict; Glenn Phillips; Nicholas LaRocca; Lynn Hudson; Richard Rudick
Journal:  Mult Scler       Date:  2017-02-16       Impact factor: 6.312

9.  Remaining visual field and preserved subjective visual functioning prevent mental distress in patients with visual field defects.

Authors:  Carolin Gall; Doreen Brösel; Bernhard A Sabel
Journal:  Front Hum Neurosci       Date:  2013-09-18       Impact factor: 3.169

10.  Longitudinal time-domain optic coherence study of retinal nerve fiber layer in IFNβ-treated and untreated multiple sclerosis patients.

Authors:  Refik Pul; Mehdi Saadat; Franco Morbiducci; Thomas Skripuletz; Ünsal Pul; Dorothee Brockmann; Kurt-Wolfram Sühs; Philipp Schwenkenbecher; Kai Günter Kahl; Kaweh Pars; Martin Stangel; Corinna Trebst
Journal:  Exp Ther Med       Date:  2016-04-27       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.